Close Menu

NEW YORK – Many diagnostics companies' stocks tumbled in February, following months of consistent increases since the end of 2020 as the 360Dx Index was down almost 4 percent month over month.

Of the 32 companies in the Index, 14 firms saw their share prices increase last month led by GenMark Diagnostics (+42 percent), Burning Rock Biotech (+19 percent), and Luminex (+16 percent). Meanwhile, 18 companies' stock prices fell, led by Quidel (-35 percent), Quotient Limited (-26 percent), and Invitae (-19 percent).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.